Pharmacotherapy, Lifestyle Modification, and Cardiac Rehabilitation after Myocardial Infarction or Percutaneous Intervention
US Cardiology Review · 09.01.2025 · 19
DOI: 10.15420/usc.2024.34 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift US Cardiology Review, online erschienen am 09.01.2025. Verfasst von Nicholas Nguyen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Methodist Dallas Medical Center Dallas, TX. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Coronary artery disease is the leading cause of death in the US, and approximately 25% of MIs occurring each year are reinfarctions. Due to advances in percutaneous coronary intervention (PCI) and medical therapy, patients with prior MIs live longer but may be susceptible to additional cardiac events. Thus, secondary prevention after MI or PCI is key to improving mortality and quality of life. This review discusses pharmacotherapies and lifestyle interventions with a special focus on cardiac rehabilitation in the post-MI or PCI period to improve cardiovascular outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Methodist Dallas Medical Center Dallas, TX.
- Division of Cardiology, Department of Internal Medicine, Dallas VA Medical Center Dallas, TX.
- University of Texas Southwestern Medical Center Dallas, TX.
Zitieren
APA
Nguyen, N., & Michelis, K. C. (2025). Pharmacotherapy, Lifestyle Modification, and Cardiac Rehabilitation after Myocardial Infarction or Percutaneous Intervention. US Cardiology Review, 19. https://doi.org/10.15420/usc.2024.34
Vancouver
Nguyen N, Michelis KC. Pharmacotherapy, Lifestyle Modification, and Cardiac Rehabilitation after Myocardial Infarction or Percutaneous Intervention. US Cardiology Review. 2025;19. doi:10.15420/usc.2024.34
BibTeX
@article{Nguyen2025,
author = {Nguyen, Nicholas and Michelis, Katherine C},
title = {Pharmacotherapy, Lifestyle Modification, and Cardiac Rehabilitation after Myocardial Infarction or Percutaneous Intervention},
journal = {US Cardiology Review},
year = {2025},
volume = {19},
doi = {10.15420/usc.2024.34}
}
EUVIMED